TrialBritish journal of clinical pharmacology2019

Effect of inotuzumab ozogamicin on the QT interval in patients with haematologic malignancies using QTc-concentration modelling.

Jennifer E Hibma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.